Skip to main content

. 1964 Jun;40(464):346–350. doi: 10.1136/pgmj.40.464.346

Carcinoid Disease: An Ever-Widening Spectrum?

A D M Smith, J R Rees, Richard D Tonkin, Harold Ellis

PMCID: PMC2482887 PMID: 14154957

346

Images in this article

Fig. 1
on p.347

Fig. 2
on p.347

Fig. 3
on p.347

Fig. 4
on p.347

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CALVERT H. T., KARLISH A. J., WELLS R. S. BRONCHIAL ADENOMA WITH THE CARCINOID SYNDROME PRESENTING WITH UNUSUAL SKIN CHANGES. Postgrad Med J. 1963 Sep;39:547–549. doi: 10.1136/pgmj.39.455.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
COMROE J. H., Jr, VAN LINGEN B., STROUD R. C., RONCORONI A. Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin); their possible role in pulmonary embolism and coronary thrombosis. Am J Physiol. 1953 Jun;173(3):379–386. doi: 10.1152/ajplegacy.1953.173.3.379. [DOI] [PubMed] [Google Scholar]
DAWES G. S., COMROE J. H., Jr Chemoreflexes from the heart and lungs. Physiol Rev. 1954 Apr;34(2):167–201. doi: 10.1152/physrev.1954.34.2.167. [DOI] [PubMed] [Google Scholar]
DENGLER H. [Atypical carcinoid syndrome with increased excretion of 5-hydroxyindolacetic acid in pancreas carcinoma]. Klin Wochenschr. 1959 Dec 1;37:1245–1248. doi: 10.1007/BF01486388. [DOI] [PubMed] [Google Scholar]
GOWENLOCK A. H., PLATT D. S., CAMPBELL A. C., WORMSLEY K. G. OAT-CELL CARCINOMA OF THE BRONCHUS SECRETING 5-HYDROXYTRYPTOPHAN. Lancet. 1964 Feb 8;1(7328):304–306. doi: 10.1016/s0140-6736(64)92411-0. [DOI] [PubMed] [Google Scholar]
HENDRIX T. R., ATKINSON M., CLIFTON J. A., INGELFINGER F. J. The effect of 5-hydroxytryptamine on intestinal motor function in man. Am J Med. 1957 Dec;23(6):886–893. doi: 10.1016/0002-9343(57)90298-x. [DOI] [PubMed] [Google Scholar]
KOWLESSAR O. D., WILLIAMS R. C., LAW D. H., SLEISENGER M. H. Urinary excretion of 5-hydroxyindolacetic acid in diarrheal states, with special reference to nontropical sprue. N Engl J Med. 1958 Aug 14;259(7):340–341. doi: 10.1056/NEJM195808142590708. [DOI] [PubMed] [Google Scholar]
MURRAY J. S., PATON R. R., POPE C. E., 2nd Pancreatic tumor associated with flushing and diarrhea. Report of a case. N Engl J Med. 1961 Mar 2;264:436–439. doi: 10.1056/NEJM196103022640905. [DOI] [PubMed] [Google Scholar]
McMULLEN F. F., Jr, HANSON H. H. Excessive urinary 5-hydroxy-3-indole acetic acid in the absence of a metastatic carcinoid. Circulation. 1958 Nov;18(5):883–886. doi: 10.1161/01.cir.18.5.883. [DOI] [PubMed] [Google Scholar]
OATES J. A., MELMON K., SJOERDSMA A., GILLESPIE L., MASON D. T. RELEASE OF A KININ PEPTIDE IN THE CARCINOID SYNDROME. Lancet. 1964 Mar 7;1(7332):514–517. doi: 10.1016/s0140-6736(64)92907-1. [DOI] [PubMed] [Google Scholar]
PEART W. S., PORTER K. A., ROBERTSON J. I., SANDLER M., BALDOCK E. Carcinoid syndrome due to pancreatic-duct neoplasm secreting 5-hydroxytryptophan and 5-hydroxytryptamine. Lancet. 1963 Feb 2;1(7275):239–243. doi: 10.1016/s0140-6736(63)90952-8. [DOI] [PubMed] [Google Scholar]
ROCHA E SILVA M., VALLE J. R., PICARELLI P. A pharmacological analysis of the mode of action of serotonin (5-hydroxytryptamine) upon the guinea-pig ileum. Br J Pharmacol Chemother. 1953 Dec;8(4):378–388. doi: 10.1111/j.1476-5381.1953.tb01333.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
WILLIAMS E. D., SANDLER M. The classification of carcinoid tum ours. Lancet. 1963 Feb 2;1(7275):238–239. doi: 10.1016/s0140-6736(63)90951-6. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES